1,919
Views
1
CrossRef citations to date
0
Altmetric
Coronavirus – Commentary

Potential changes in vaccine access and policy landscape in Thailand post COVID-19 pandemic

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2095823 | Received 10 May 2022, Accepted 24 Jun 2022, Published online: 11 Jul 2022

References

  • Rémy V, Zöllner Y, and Heckmann U. Vaccination: the cornerstone of an efficient healthcare system. Journal of Market Access & Health Policy. 2015;3(1):1 doi:10.3402/jmahp.v3.27041.
  • Greenwood B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci. 2014;369(1645). doi:10.1098/rstb.2013.0433.
  • Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, Lee BW, Lolekha S, Peltola H, Ruff TA, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008;86(2):140–7. doi:10.2471/BLT.07.040089.
  • UNICEF. Socio-economic impact assessment of COVID-19 in Thailand 2020.
  • World Health Organization. WHO Coronavirus (COVID-19) dashboard. Geneva; 2021.
  • Office NHS. About NHSO. Bangkok; 2021.
  • National Health Security Office. National health security act B.E.2545 (A.D.2002). Bangkok; 2021.
  • National Vaccine Committee. Draft of the national policy and strategic plan for vaccine security 2023-2027. Institute TNV, editor. Bangkok; 2021.
  • National vaccine security act. 2019 Nov 21. p. 50–71.
  • National vaccine committee regulations: funding encouragement and cooporation for vaccine research & development, and production. Committee NV, editor. Bangkok; 2019.
  • Thai Food and Drug Administration. Guideline on quality, non-clinical and clinical assessment regarding market authorizations of vaccines in Thailand. 2008.
  • World Health Organization. Guidelines for independent lot release of vaccines by regulatory authorities, Annex 2, TRS No 978. Geneva; 2010.
  • Riewpaiboon A, Sooksriwong C, Chaiyakunapruk N, Tharmaphornpilas P, Techathawat S, Rookkapan K, Rasdjarmrearnsook A, Suraratdecha C. Optimizing national immuniation program supply chain management in Thailand: an economic analysis. Public Health. 2015;129(7):899–906. doi:10.1016/j.puhe.2015.04.016.
  • AstraZeneca. AstraZeneca’s COVID-19 vaccine manufactured in Thailand authorised for World Health Organization emergency use. 2021.
  • Office of the Assistant Secretary for Preparedness & Response. Biomedical advanced research and development authority. Washington (DC); 2022.
  • Health Intervention and Technology Assessment Program. A review and recommendations for fiscal and monetary policy management of immunization systems in Thailand. 2020.
  • National Vaccine Committee. Draft of the national policy and strategic plan for vaccine security 2019-2022. Institute TNV, editor. Bangkok; 2017.
  • World Health O. Increasing access to vaccines through technology transfer and local production. Geneva: World Health Organization; 2011.
  • Peacocke EF, Heupink LF, Frønsdal K, Dahl EH, Chola L. Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries. BMJ Open. 2021;11(9):e049505. doi:10.1136/bmjopen-2021-049505.
  • Onishchenko K, Hill S, Wasserman M, Jones C, Moffatt M, Ruff L, Pugh SJ. Trends in vaccine investment in middle income countries. Hum Vaccin Immunother. 2019;15(10):2378–2385. doi:10.1080/21645515.2019.1589287.